Autopsy report · NCT02268136
Increasing Dose Tolerance Study in Healthy Male Volunteers After Administration of BIII 890 CL
Cause of deathNo reason given
Life of this trial
- Registered 15 years 6 months after it had already started.
- 76 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Boehringer Ingelheim
- Sponsor type
- Industry
- Conditions
- Healthy
- Interventions
- BIII 890 CL; Placebo
- Participants
- 76
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.